Cargando…

Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors

A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC(50) values ranging fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ping, Zeng, Jia-Cheng, Chen, Ji-Guang, Nie, Xu-Liang, Yuan, En, Wang, Xiao-Qiang, Peng, Da-Yong, Yin, Zhong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580737/
https://www.ncbi.nlm.nih.gov/pubmed/33003963
http://dx.doi.org/10.1080/14756366.2020.1826941
_version_ 1783598836873166848
author Lin, Ping
Zeng, Jia-Cheng
Chen, Ji-Guang
Nie, Xu-Liang
Yuan, En
Wang, Xiao-Qiang
Peng, Da-Yong
Yin, Zhong-Ping
author_facet Lin, Ping
Zeng, Jia-Cheng
Chen, Ji-Guang
Nie, Xu-Liang
Yuan, En
Wang, Xiao-Qiang
Peng, Da-Yong
Yin, Zhong-Ping
author_sort Lin, Ping
collection PubMed
description A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC(50) values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC(50) = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds 43, 40, and 34 were all competitive inhibitors on α-glucosidase with K(i)of 10 µM, 52 µM, and 150 µM, respectively. Molecular docking demonstrated that the high active inhibitors interacted with α-glucosidase by four types of interactions, including hydrogen bonds, π–π stacking interactions, hydrophobic interactions, and electrostatic interaction. Among all the interactions, the π–π stacking interaction and hydrogen bond played a significant role in a various range of activities of the compounds.
format Online
Article
Text
id pubmed-7580737
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-75807372020-10-29 Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors Lin, Ping Zeng, Jia-Cheng Chen, Ji-Guang Nie, Xu-Liang Yuan, En Wang, Xiao-Qiang Peng, Da-Yong Yin, Zhong-Ping J Enzyme Inhib Med Chem Research Paper A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC(50) values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC(50) = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds 43, 40, and 34 were all competitive inhibitors on α-glucosidase with K(i)of 10 µM, 52 µM, and 150 µM, respectively. Molecular docking demonstrated that the high active inhibitors interacted with α-glucosidase by four types of interactions, including hydrogen bonds, π–π stacking interactions, hydrophobic interactions, and electrostatic interaction. Among all the interactions, the π–π stacking interaction and hydrogen bond played a significant role in a various range of activities of the compounds. Taylor & Francis 2020-10-01 /pmc/articles/PMC7580737/ /pubmed/33003963 http://dx.doi.org/10.1080/14756366.2020.1826941 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Lin, Ping
Zeng, Jia-Cheng
Chen, Ji-Guang
Nie, Xu-Liang
Yuan, En
Wang, Xiao-Qiang
Peng, Da-Yong
Yin, Zhong-Ping
Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
title Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
title_full Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
title_fullStr Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
title_full_unstemmed Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
title_short Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
title_sort synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel n-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580737/
https://www.ncbi.nlm.nih.gov/pubmed/33003963
http://dx.doi.org/10.1080/14756366.2020.1826941
work_keys_str_mv AT linping synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors
AT zengjiacheng synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors
AT chenjiguang synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors
AT niexuliang synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors
AT yuanen synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors
AT wangxiaoqiang synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors
AT pengdayong synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors
AT yinzhongping synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors